Latest Market Outlook News

Page 24 of 38
MyEco Group reported an 8.6% increase in FY25 sustainable product sales, driven by strong growth in its MyEco® brand globally. The company is executing an operational restructure expected to deliver $2.5 million in cost savings in FY26 while navigating volatile resin markets and US tariff uncertainties.
Maxwell Dee
Maxwell Dee
28 July 2025
Power Minerals has received crucial environmental and hydrological approvals to begin drilling at its Pocitos Project in Argentina, a vital step toward establishing a lithium carbonate production hub in the Lithium Triangle.
Maxwell Dee
Maxwell Dee
28 July 2025
Advanced Health Intelligence Ltd (AHI) reports robust commercial progress and strategic funding moves in Q1 2025 despite ongoing ASX trading suspension and recent NASDAQ delisting. Key partnerships and technology validations position the company for a strong global scale-up.
Ada Torres
Ada Torres
25 July 2025
Pursuit Minerals has issued over 8.5 million placement options and additional shares to directors following shareholder approval, setting the stage for potential capital inflows through option exercises by mid-2027.
Maxwell Dee
Maxwell Dee
25 July 2025
Gibb River Diamonds has commenced grade control drilling at its Neta Prospect in Western Australia, moving closer to potential mining operations pending regulatory approval.
Maxwell Dee
Maxwell Dee
24 July 2025
Tshipi é Ntle has declared a ZAR300 million final dividend for FY2025 H2, with Jupiter Mines set to receive approximately A$12.3 million. This payout underscores the manganese mine’s robust cash flow generation amid market cycles.
Maxwell Dee
Maxwell Dee
24 July 2025
Amplia Therapeutics has launched a $27.5 million capital raising to advance its lead drug Narmafotinib, a promising FAK inhibitor showing superior efficacy in pancreatic cancer trials. The funds will support ongoing and new clinical studies, positioning the company for pivotal regulatory milestones.
Ada Torres
Ada Torres
23 July 2025
Race Oncology has safely treated the first patient with its RC220 drug alone and in combination with doxorubicin in a Phase 1 trial, while bolstering its clinical leadership and maintaining a strong cash position to fund operations through 2026.
Ada Torres
Ada Torres
23 July 2025
Iluka Resources has met its full-year zircon-in-concentrate production guidance by mid-2025 while progressing key projects like Balranald and Eneabba amid ongoing global trade uncertainties.
Maxwell Dee
Maxwell Dee
23 July 2025
BKI Investment Company posted a solid financial performance for FY2025 with a 1% increase in dividends and introduced a neutralised Dividend Reinvestment Plan to maintain capital neutrality. Despite modest portfolio underperformance against major ETFs, BKI continues to offer an attractive dividend yield amid shifting market dynamics.
Claire Turing
Claire Turing
21 July 2025
Lode Resources has received initial tin assay results from its ongoing drilling at the Montezuma Antimony & Silver Project, significantly enhancing previously reported high-grade intercepts and underscoring the polymetallic nature of the deposit.
Maxwell Dee
Maxwell Dee
21 July 2025
BHP has reported record copper and iron ore production for FY25, while revising upward the capital cost and timeline for its Jansen Stage 1 potash project. The miner’s operational strength contrasts with ongoing challenges in nickel and coal segments.
Maxwell Dee
Maxwell Dee
18 July 2025